Cardiff Lexington Corp (CDIX)

[~ Blue ~]

CDIX news mentioned 3 Private Equity firms. It means Acela acquisition is on the way. If these private equity firms didn't believe the deal they would not fund the company in my honest opinion.


http://leonitecap.com

https://www.craftcm.com

http://gtfinancial.com




Cardiff Lexington Corporation (CDIX) Shores Up Balance Sheet with Capital Infusion; Eliminates Convertible Debts


Email Print Friendly Share
September 11, 2019 08:45 ET | Source: Cardiff Lexington
FT. LAUDERDALE, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Cardiff Lexington (OTC: CDIX) Cardiff Lexington, a public holding company, today announced that the Company has received $410,000.00 in new funding from the Private Equity Group, Leonite Capital, LLC. The parties entered into a 12-month conventional note. This capital infusion was arranged by the registered Broker Dealer Craft Capital, LLC to stop the current convertible note dilution of Cardiff Lexington common stock and in an attempt to stabilize the share price of the Company.

Cardiff has paid-off three significant convertible notes totaling $379,902 and plans to retire all commercial notes by year end 2019 in concert with acquisition related equity funding. This move consolidates Company debt with essentially two friendly lenders Leonite Capital LLC and Greentree Financial, LLC both of whom have invested prior, are committed to future equity participations, and are aligned and committed to Cardiff Lexington’s future goals and objectives.

Alex Cunningham, CEO/President of Cardiff Lexington, stated: “The elimination of troubling debt conversions from our balance sheet and move to an equity blend of financing should have a positive effect to help strengthen the value of our company and our common share market price. Paying off this currently converting convertible debt, will dramatically ease troubling dilution which has consistently put extreme pressure on our common stock price. Our goal is to continue to reward our shareholders and new investors of Cardiff Lexington by organic growth through an increasing common stock price and expanding our revenue streams through new acquisitions including real estate and companies vertically and horizontally aligned with the CBD Oil Medical Hemp business. ” “These moves combined with our pending potential Acela BioMedical acquisition in my opinion will immediately validate our higher standing within the small cap market segment as we continue to gain national attention of our business strategy as one of the more stable innovative fully reporting Companies in our industry,” further stated Cunningham.


http://www.globenewswire.com/news-release/2019/09/11/1914147/0/en/Cardiff-Lexington-Corporation-CDIX-Shores-Up-Balance-Sheet-with-Capital-Infusion-Eliminates-Convertible-Debts.html